GLORIA

GEOMAR Library Ocean Research Information Access

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
Filter
  • Ovid Technologies (Wolters Kluwer Health)  (5)
Material
Publisher
  • Ovid Technologies (Wolters Kluwer Health)  (5)
Language
Years
  • 1
    In: NeuroReport, Ovid Technologies (Wolters Kluwer Health), Vol. 32, No. 15 ( 2021-10-13), p. 1248-1254
    Abstract: The aim of this study was to investigate the potential therapeutic effects of a newly discovered osteopontin-derived synthetic peptide “RSKKFRR” in a rat model of ischemic stroke. Methods A total of 24 male SD rats were randomly divided into three groups. The model of ischemic stroke was made up of the middle cerebral artery occlusion (MACO). The rats were divided into sham operation group (Sham), control group (MACO + PBS) and treatment group (MACO + OPNpt9), eight rats in each group. In the control group and the treatment group, PBS or OPNpt9 was injected into the nasal cavity after MACO once a day, and the area of new blood vessels and the recovery of nerve function were observed 14 days later. Whether the proliferation, migration and tube formation of HUVECs were promoted by OPNpt9 was tested. The expression levels of related proangiogenic factors were also detected. Results OPNpt9 was found to contribute to cerebral microvascular remodeling and neurological improvement in ischemic rats while promoting endothelial cell migration, proliferation and tube formation in vitro. These effects were mediated by activation of the p-ERK/MMP-9/VEGF pathway. Conclusion In conclusion, OPNpt9 promotes angiogenesis and neurological recovery after ischemic stroke.
    Type of Medium: Online Resource
    ISSN: 0959-4965
    Language: English
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date: 2021
    detail.hit.zdb_id: 2031485-1
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 2
    In: Chinese Medical Journal, Ovid Technologies (Wolters Kluwer Health), Vol. Publish Ahead of Print ( 2022-12-28)
    Type of Medium: Online Resource
    ISSN: 2542-5641
    Language: English
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date: 2022
    detail.hit.zdb_id: 2108782-9
    SSG: 6,25
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 3
    In: Medicine, Ovid Technologies (Wolters Kluwer Health), Vol. 102, No. 8 ( 2023-02-22), p. e33010-
    Abstract: Exercise training significantly improves cardiorespiratory fitness (CRF) in heart failure with reduced ejection fraction (HFrEF) patients, but high-intensity interval training (HIIT) is not superior to moderate-intensity interval training (MIIT). Whether HIIT is more beneficial than MIIT in patients with heart failure with preserved ejection fraction (HFpEF) remains unclear. Methods: On August 29, 2021, we conducted a comprehensive computerized literature search of the Medline, EMBASE, Web of Science, and Cochrane databases using the following keywords: “HF or diastolic HF or HFpEF or HF with normal ejection fraction and exercise training or aerobic exercise or isometric exercises or physical activity or cardiac rehabilitation.” Only randomized controlled trials (RCTs) reporting comparisons between HIIT and MIIT in HFpEF were included in the final analysis to maintain consistency and obtain robust pooled estimates. Methodological quality was assessed based on the ratings of individual biases. To generate an overall test statistic, the data were analyzed using the random-effects model for a generic inverse variance. Outcome measures were reported as an odds ratio, and confidence intervals (CIs) were set at 95%. The study followed PRISMA guidelines. Results: This meta-analysis included only RCTs comparing the efficacy of HIIT and MIIT in HFpEF patients. This study included 150 patients from 3 RCTs. In the current pooled data analysis, HIIT significantly improves diastolic function measured by E/A ratio (WMD, 0.13; 95% CI, 0.03–0.23, P = .009). However, no significant change was observed in the diastolic function measured by E/e’ ratio (WMD, 0.39; 95% CI, −2.40 to 3.18, P = .78), and CRF evaluated by both VO 2 (mL/kg per min; WMD, −0.86; 95%CI, −5.27 to 3.55, P = .70) and VE/CO 2 slope (WMD, 0.15; 95% CI, −10.24 to 10.53, P = .98), and systolic function (EF-WMD, −2.39; 95% CI, −12.16% to 7.38%, P = .63) between HIIT and MIIT in patients with HFpEF. Conclusion: In HFpEF patients, HIIT may be superior to MIIT in improving diastolic function, measured by E/A, but not CRF and left ventricular systolic function.
    Type of Medium: Online Resource
    ISSN: 0025-7974
    Language: English
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date: 2023
    detail.hit.zdb_id: 2049818-4
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 4
    In: Circulation, Ovid Technologies (Wolters Kluwer Health), Vol. 146, No. Suppl_1 ( 2022-11-08)
    Abstract: Background: Tumor endothelial marker 1 (TEM1 or CD248) is a transmembrane protein that expresses in mesenchymal lineage-derived cells only during embryogenesis. Re-upregulation of TEM1 in fibroblasts has been found in hepatic fibrosis, renal fibrosis and wound healing. Atrial fibrosis plays an important role in atrial fibrillation (AF) and stroke. We evaluated TEM1 expression in atrial fibrosis and its physiological significance. Methods and Results: All data were presented as mean ± standard error. In 10 patients (pts) with AF undergoing indicated cardiac surgery and Maze procedure, left atrial (LA) appendage was excised. Immunofluorescence staining showed TEM1 expressed in LA cardiac fibroblasts (CFs) in AF pts but not in normal LA tissue purchased from the US Biomax, Inc. Sirius Red staining showed more LA fibrosis in AF than normal LA tissue (7.51±0.40% vs. 3.80±0.51%, p 〈 0.01). In AF pts, higher LA TEM1 expression detected by western blotting was associated with larger LA fibrosis. In 20 AF pts (15 men, mean age 57.5 ± 2.8 yrs) undergoing catheter ablation, LA blood samples were taken and soluble TEM1 (sTEM1) was measured by ELISA. Peak atrial longitudinal strain (PALS) measured by speckle tracking echocardiography before ablation was used as an atrial fibrosis marker. There was a significantly negative correlation of the sTEM1 levels in LA with PALS (ρ=-0.453, p 〈 0.05) indicating increased sTEM1 was associated with atrial fibrosis. In vitro study showed recombinant TEM1 protein (rTEM1) increased proliferation of cultured CFs (saline vs rTEM1 10, 50 and 100 nM, BrdU absorbance: 0.55±0.02 vs. 0.62±0.04 vs. 0.73±0.04 vs. 0.74±0.04, p 〈 0.05) and reduced starvation-induced apoptosis (cell death ELISA absorbance: 1.06±0.09 vs. 0.61±0.05 vs. 0.49±0.11 vs. 0.33±0.02, p 〈 0.05). Transwell assay showed rTEM1 induced increased CFs migration. Conclusions: The study results indicate that TEM1 upregulation in CFs is associated with atrial fibrosis and TEM1 changes the cell behaviors of CFs. Further studies are undergoing to clarify if TEM1 knockdown could alleviate atrial fibrosis.
    Type of Medium: Online Resource
    ISSN: 0009-7322 , 1524-4539
    Language: English
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date: 2022
    detail.hit.zdb_id: 1466401-X
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 5
    Online Resource
    Online Resource
    Ovid Technologies (Wolters Kluwer Health) ; 2017
    In:  Chinese Medical Journal Vol. 130, No. 5 ( 2017-03-05), p. 600-606
    In: Chinese Medical Journal, Ovid Technologies (Wolters Kluwer Health), Vol. 130, No. 5 ( 2017-03-05), p. 600-606
    Type of Medium: Online Resource
    ISSN: 0366-6999
    Language: English
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date: 2017
    detail.hit.zdb_id: 2108782-9
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...